These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 28050754

  • 1. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
    Lauffenburger JC, Landon JE, Fischer MA.
    J Gen Intern Med; 2017 Jun; 32(6):619-625. PubMed ID: 28050754
    [Abstract] [Full Text] [Related]

  • 2. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

  • 3. [Medication adherence with the fixed combination of ramipril and amlodipine].
    Simonyi G, Ferenci T.
    Orv Hetil; 2014 Nov 23; 155(47):1882-8. PubMed ID: 25403283
    [Abstract] [Full Text] [Related]

  • 4. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
    Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S.
    J Manag Care Spec Pharm; 2019 Jun 23; 25(6):678-686. PubMed ID: 31134857
    [Abstract] [Full Text] [Related]

  • 5. [One year adherence of ramipril versus ramipril/amlodipine fixed dose combination therapy in hypertension].
    Simonyi G, Ferenci T.
    Orv Hetil; 2017 Oct 23; 158(42):1669-1673. PubMed ID: 29037057
    [Abstract] [Full Text] [Related]

  • 6. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.
    BMC Fam Pract; 2008 Nov 06; 9():61. PubMed ID: 18990240
    [Abstract] [Full Text] [Related]

  • 7. Comparison of therapy persistence for fixed versus free combination antihypertensives: a retrospective cohort study.
    Grimmsmann T, Himmel W.
    BMJ Open; 2016 Nov 22; 6(11):e011650. PubMed ID: 27881519
    [Abstract] [Full Text] [Related]

  • 8. Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
    Degli Esposti L, Perrone V, Veronesi C, Gambera M, Nati G, Perone F, Tagliabue PF, Buda S, Borghi C.
    Curr Med Res Opin; 2018 Sep 22; 34(9):1571-1577. PubMed ID: 29376432
    [Abstract] [Full Text] [Related]

  • 9. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
    Verma AA, Khuu W, Tadrous M, Gomes T, Mamdani MM.
    PLoS Med; 2018 Jun 22; 15(6):e1002584. PubMed ID: 29889841
    [Abstract] [Full Text] [Related]

  • 10. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun 22; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 11. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Jan 03; 157(1):30-4. PubMed ID: 26708684
    [Abstract] [Full Text] [Related]

  • 12. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE.
    J Med Econ; 2012 Jan 03; 15(1):155-65. PubMed ID: 22035215
    [Abstract] [Full Text] [Related]

  • 13. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK, Lee SG, Lee KS, Kim DS, Kim KH, Kim KY.
    Clin Ther; 2009 Jun 03; 31(6):1309-20. PubMed ID: 19695396
    [Abstract] [Full Text] [Related]

  • 14. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.
    Du LP, Cheng ZW, Zhang YX, Li Y, Mei D.
    J Clin Hypertens (Greenwich); 2018 May 03; 20(5):902-907. PubMed ID: 29700923
    [Abstract] [Full Text] [Related]

  • 15. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
    Panjabi S, Lacey M, Bancroft T, Cao F.
    J Am Soc Hypertens; 2013 May 03; 7(1):46-60. PubMed ID: 23321404
    [Abstract] [Full Text] [Related]

  • 16. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV.
    Manag Care; 2013 Dec 03; 22(12):45-55. PubMed ID: 24555265
    [Abstract] [Full Text] [Related]

  • 17. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Dec 03; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 18. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
    Simonyi G, Ferenci T.
    Orv Hetil; 2016 Mar 13; 157(11):425-9. PubMed ID: 26947091
    [Abstract] [Full Text] [Related]

  • 19. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.
    Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS.
    Drugs Aging; 2008 Mar 13; 25(10):885-92. PubMed ID: 18808213
    [Abstract] [Full Text] [Related]

  • 20. Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?
    Bartlett LE, Pratt N, Roughead EE.
    Curr Med Res Opin; 2018 Feb 13; 34(2):305-311. PubMed ID: 28945105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.